Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review

ConclusionOur work was able to show that SM could be proposed as a consolidation treatment to excise residual lesions that were deemed unresectable prior to a combination of systemic therapies. Contrastingly, it can be proposed as an upfront treatment, leaving systemic therapies as an alternative in case of future relapse. However, patient selection regarding their performance status, metastatic sites, number of lesions and tumorous characteristics is of paramount importance.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research